The global Precision Medicine Market is expected to reach USD 132.66 Billion by 2027, according to a new report by Emergen Research. The comprehensive study covers hard to find facts about the market landscape as well as its growth prospects in the years to come. Most importantly, the research report includes vital statistics about the major vendors occupying a strong foothold in this industry.
Besides this, in order to calculate the market share, the study takes a closer look at the selling price of the product across different regions.
Read more@ https://www.emergenresearch.com/industry-report/precision-medicine-market
Key Highlights Of Precision Medicine Market –
- The oncology application is the major contributor to the Precision Medicine Market. The segment is growing due to the rising frequency and prevalence of cancer worldwide, which will intensify the demand for precision medicine as an essential form of therapy coupled with developing tailored treatments for patients with cancer dependent on their genetic makeup over traditional chemotherapy.
- North America dominated the market for Precision Medicine in 2019. The region’s consistent focus on cost-effective and innovative procedures that are adopted in the area is driving the market.
Top Players: Biocrates Life Sciences, Tepnel Pharma Services, Menarini Silicon Biosystems, NanoString Technologies, Quest Diagnostics, Qiagen, Teva Pharmaceutical, Eagle Genomics, Novartis, and Pfizer, among others.
The global Precision Medicine Market on the basis of technology, end-use, application, and region:
- Technology Outlook (Revenue: USD Billion; 2017-2027)
- Big Data Analytics
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Companion Diagnostics
- Others
- End-Use Outlook (Revenue: USD Billion; 2017-2027)
- Pharmaceutical Companies
- Diagnostic Companies
- Healthcare IT companies
- Others
- Application Outlook (Revenue: USD Billion; 2017-2027)
- Oncology
- Immunology
- CNS
- Respiratory
- Others
- Regional Outlook (Revenue, USD Billion; 2017-2027)
North America; Europe; Asia Pacific; Central & South America; MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Precision Medicine Market Segmentation & Impact Analysis
4.1. Precision Medicine Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rise in the online collaborative forums in developed economies Increased adoption of gene therapy globally
4.2.2.2. Increasing usage of big data analytics in precision medicine in developing economies
4.2.3. Market restraints analysis
4.2.3.1. High cost of precision medicine
4.2.3.2. Violation of the privacy rule and misinterpretation of genetic and health data
4.2.3.3. Reimbursement challenges
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
Continued…
